A Platform for Screening Potential Anticholinesterase Fractions and Components Obtained from <i>Anemarrhena asphodeloides</i> Bge for Treating Alzheimer’s Disease

<table>The proposed structures of the fifteen compounds identified by Q-TOF-MS.</table>

Evidence-Based Complementary and Alternative Medicine

fig6

Figure 6

Figure 6: A Platform for Screening Potential Anticholinesterase Fractions and Components Obtained from <i>Anemarrhena asphodeloides</i> Bge for Treating Alzheimer’s Disease 

Figure 6 | A Platform for Screening Potential Anticholinesterase Fractions and Components Obtained from Anemarrhena asphodeloides Bge for Treating Alzheimer’s Disease 